Active Ingredient History
Ifosfamide (IFO), sold under the brand name Ifex among others, is a chemotherapy medication used to treat a number of types of cancer. This includes testicular cancer, soft tissue sarcoma, osteosarcoma, bladder cancer, small cell lung cancer, cervical cancer, and ovarian cancer. It is administered by injection into a vein. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Testicular Neoplasms (approved 1987)
Biomarkers (Phase 2)
Bone Neoplasms (Phase 1)
Brain Neoplasms (Phase 3)
Breast Neoplasms (Phase 3)
Burkitt Lymphoma (Phase 4)
Carcinoma (Phase 2)
Carcinoma, Embryonal (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 3)
Carcinoma, Transitional Cell (Phase 2)
Cardiotoxicity (Phase 3)
Central Nervous System Neoplasms (Phase 2)
Chemotherapy, Cancer, Regional Perfusion (Phase 2)
Chondrosarcoma (Phase 3)
Chondrosarcoma, Mesenchymal (Phase 2/Phase 3)
Choriocarcinoma (Phase 3)
Clonal Hematopoiesis (Phase 2)
Dermatofibrosarcoma (Phase 3)
Dermatology (Phase 2/Phase 3)
Desmoplastic Small Round Cell Tumor (Phase 2)
Endodermal Sinus Tumor (Phase 3)
Endometrial Neoplasms (Phase 3)
Enteropathy-Associated T-Cell Lymphoma (Phase 4)
Fallopian Tube Neoplasms (Phase 3)
Fibrosarcoma (Phase 3)
Germinoma (Phase 3)
Hamartoma (Phase 4)
Head and Neck Neoplasms (Phase 2)
Histiocytic Sarcoma (Phase 2/Phase 3)
HIV (Phase 2)
Hodgkin Disease (Phase 3)
Informed Consent (Phase 2)
Intestinal Neoplasms (Phase 2)
Kidney Diseases (Phase 1)
Kidney Neoplasms (Phase 3)
Leiomyosarcoma (Phase 3)
Leukemia (Phase 3)
Leukemia, B-Cell (Phase 1/Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 4)
Leukemia-Lymphoma, Adult T-Cell (Phase 1/Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Liposarcoma (Phase 3)
Liposarcoma, Myxoid (Phase 2)
Liver Neoplasms (Phase 1/Phase 2)
Lung Neoplasms (Phase 3)
Lymphangiosarcoma (Phase 2)
Lymphoma (Phase 4)
Lymphoma, B-Cell (Phase 4)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 4)
Lymphoma, Large-Cell, Anaplastic (Phase 4)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 4)
Lymphoma, T-Cell (Phase 4)
Lymphoma, T-Cell, Peripheral (Phase 4)
Lymphomatoid Granulomatosis (Phase 1/Phase 2)
Mediastinal Neoplasms (Phase 4)
Meningioma (Phase 2)
Multiple Myeloma (Phase 3)
Mutation (Phase 3)
Mycosis Fungoides (Phase 1)
Myelodysplastic Syndromes (Phase 1/Phase 2)
Myeloproliferative Disorders (Phase 1/Phase 2)
Myosarcoma (Phase 2)
Nasopharyngeal Carcinoma (Phase 2)
Nasopharyngeal Neoplasms (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 4)
Nerve Sheath Neoplasms (Phase 2/Phase 3)
Neuroblastoma (Phase 3)
Neuroectodermal Tumors (Phase 3)
Neuroectodermal Tumors, Primitive (Phase 1)
Neuroendocrine Tumors (Phase 1)
Neurofibromatosis 1 (Phase 2)
Neurofibrosarcoma (Phase 2/Phase 3)
Neutropenia (Phase 2)
Osteosarcoma (Phase 3)
Ovarian Diseases (Phase 3)
Ovarian Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 2)
Penile Neoplasms (Phase 2)
Perivascular Epithelioid Cell Neoplasms (Phase 2/Phase 3)
Pheochromocytoma (Phase 3)
Precancerous Conditions (Phase 1/Phase 2)
Retinoblastoma (Phase 1)
Rhabdomyosarcoma (Phase 3)
Sarcoma (Phase 4)
Sarcoma, Alveolar Soft Part (Phase 2/Phase 3)
Sarcoma, Clear Cell (Phase 2/Phase 3)
Sarcoma, Ewing (Phase 3)
Sarcoma, Synovial (Phase 3)
Seminoma (Phase 3)
Sepsis (Phase 3)
Sezary Syndrome (Phase 1/Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Stomatitis (Phase 2)
Survival (Phase 2)
Teratoma (Phase 3)
Testicular Neoplasms (Phase 3)
Thymoma (Phase 1)
Thyroid Neoplasms (Phase 1/Phase 2)
Triple Negative Breast Neoplasms (Phase 3)
Urethral Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 3)
Uterine Neoplasms (Phase 3)
Waldenstrom Macroglobulinemia (Phase 1/Phase 2)
Wilms Tumor (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
